SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001223203-08-000095
Filing Date
2008-05-27
Accepted
2008-05-27 12:29:40
Documents
1
Period of Report
2008-05-22

Document Format Files

Seq Description Document Type Size
1 ger381.html 4  
1 ger381.xml 4 6422
  Complete submission text file 0001223203-08-000095.txt   8332
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Issuer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5086209700
GERAGHTY JAMES A (Reporting) CIK: 0001239746 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14680 | Film No.: 08859968